Correlation Between Novartis and HUTCHMED DRC
Can any of the company-specific risk be diversified away by investing in both Novartis and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG ADR and HUTCHMED DRC, you can compare the effects of market volatilities on Novartis and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and HUTCHMED DRC.
Diversification Opportunities for Novartis and HUTCHMED DRC
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Novartis and HUTCHMED is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG ADR and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG ADR are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of Novartis i.e., Novartis and HUTCHMED DRC go up and down completely randomly.
Pair Corralation between Novartis and HUTCHMED DRC
Considering the 90-day investment horizon Novartis AG ADR is expected to generate 0.4 times more return on investment than HUTCHMED DRC. However, Novartis AG ADR is 2.48 times less risky than HUTCHMED DRC. It trades about -0.07 of its potential returns per unit of risk. HUTCHMED DRC is currently generating about -0.07 per unit of risk. If you would invest 9,608 in Novartis AG ADR on January 21, 2024 and sell it today you would lose (172.00) from holding Novartis AG ADR or give up 1.79% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novartis AG ADR vs. HUTCHMED DRC
Performance |
| Timeline |
| Novartis AG ADR |
| HUTCHMED DRC |
Novartis and HUTCHMED DRC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novartis and HUTCHMED DRC
The main advantage of trading using opposite Novartis and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.| Novartis vs. Alkermes Plc | Novartis vs. Ironwood Pharmaceuticals | Novartis vs. Deciphera Pharmaceuticals LLC | Novartis vs. Eagle Pharmaceuticals |
| HUTCHMED DRC vs. Alkermes Plc | HUTCHMED DRC vs. Ironwood Pharmaceuticals | HUTCHMED DRC vs. Deciphera Pharmaceuticals LLC | HUTCHMED DRC vs. Eagle Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |